Loading...
Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab
The tumor biology targeted therapies have improved outcomes in colorectal cancer (CRC). The epidermal growth factor receptor (EGFR) inhibitors represent one of these successful strategies. EGFR is frequently overexpressed in CRCs and associated with a malignant phenotype. Two EGFR inhibitors have sh...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2886332/ https://ncbi.nlm.nih.gov/pubmed/20616903 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|